Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuzheng Jiedu Huayu is a traditional Chinese medicine (TCM) herbal formulation developed by Beijing Ditan Hospital. It is used primarily for the prevention and treatment of tumors and infectious diseases, as well as certain digestive system disorders. The decoction is composed of multiple herbs with purported effects such as "invigorating qi," "detoxification," and "removing blood stasis." Mechanistically, it has demonstrated antibacterial activity against multidrug-resistant Pseudomonas aeruginosa by inhibiting biofilm formation through suppression of the MexAB-OprM efflux pump and quorum sensing systems. Clinical studies suggest it can enhance the efficacy of antibiotics in pneumonia and may reduce toxicity while improving outcomes when combined with immunotherapy or antiviral agents in hepatitis B virus-related hepatocellular carcinoma. Its active components include quercetin, baicalein, luteolin, kaempferol, and β-sitosterol[1][2][3][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuzheng Jiedu Huayu.